M&R Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
$200K Hold
2,000
0.04% 132
2024
Q2
$169K Hold
2,000
0.04% 139
2024
Q1
$146K Buy
+2,000
New +$146K 0.04% 148